SURMOUNT-1 is an obesity drug trial for Tirzepatide that is currently going through the clinical trials to determine whether it is safe and effective. This medication has not yet received the approval it needs from the US Food and Drug Administration (FDA) to be legally prescribed and sold in the United States. That said, it is in the process of doing so.
(more…)